Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases
- 24 August 2016
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 63 (12), 2221-2229
- https://doi.org/10.1002/pbc.26141
Abstract
Donor mixed chimerism (MC) is an increasing problem after hematopoietic stem cell transplantation (HSCT) for nonmalignant diseases. In this study, a self-administered questionnaire was used to retrospectively compare efficacy and safety in 49 patients undergoing second HSCT (n = 13) or donor lymphocyte infusion (DLI; n = 36) as treatment for MC. The response rate to DLI of patients with secondary graft failure (GF) (25.0%) was significantly lower than that of patients without secondary GF (81.3%; P = 0.041). Among patients undergoing DLI, the rates of successful response were significantly higher in patients having at least 30% donor chimerism (94.1%) than in patients having less than 30% donor chimerism (61.1%; P = 0.041). Furthermore, the rates of successful response were significantly higher in patients receiving larger first or maximum doses of DLI. Sixteen (50.0%) of 32 patients without secondary GF attained complete chimerism after DLI. The cumulative incidence of grade II-IV acute graft-versus-host disease and cytopenia was 37.6 and 26.1%, respectively. DLI yields promising response rates in most patients with higher donor chimerism levels, whereas second HSCT is more likely to benefit patients with lower donor chimerism levels.Keywords
Funding Information
- Grant-in-Aid for Scientific Research (C) (24591407)
This publication has 16 references indexed in Scilit:
- Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism after a Reduced-Intensity Preparative Regimen for Pediatric Patients with Nonmalignant DiseasesTransplantation and Cellular Therapy, 2014
- A multicentre UK study of GVHD following DLI: Rates of GVHD are high but mortality from GVHD is infrequentBone Marrow Transplantation, 2014
- Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficienciesExpert Review of Clinical Immunology, 2012
- Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantationBlood, 2010
- Hematopoietic Stem Cell Transplantation for Bone Marrow Failure Syndromes in ChildrenTransplantation and Cellular Therapy, 2009
- Graft-versus-host disease after donor leukocyte infusions: presentation and managementBest Practice & Research Clinical Haematology, 2008
- Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP systemInternational Journal of Hematology, 2007
- Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in childrenThe Lancet, 2004
- Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelinesBone Marrow Transplantation, 2003
- Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.Cancer Control, 2002